Ozempic, Wegovy, and Mounjaro Lawsuit Attorneys

GLP-1 Drugs Linked to Serious Side Effects

Drugs like Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity—part of the GLP-1 class—are widely prescribed for diabetes and weight loss. But behind the success stories, thousands are now coming forward after suffering from severe, even life-altering side effects, including:

• Gastroparesis (stomach paralysis)

• Pancreatitis

• Gallbladder disease

• Thyroid tumors

• Severe gastrointestinal distress

If you or a loved one suffered after taking a GLP-1 drug, you’re not alone—and you may have legal options.

Severe Injuries and Complications Reported

Some patients have reported life-altering injuries and serious health risks associated with GLP-1 drugs, including:

Gastroparesis (Stomach Paralysis)

• Delayed stomach emptying leading to bloating, nausea, and vomiting

• May result in hospitalizations and long-term dietary restrictions

Pancreatitis

• Inflammation of the pancreas, causing severe abdominal pain and digestive issues

• A known risk flagged by the FDA for some GLP-1 medications

Gallbladder Disease

• Includes gallstones and cholecystitis (inflammation)

• May require surgical removal of the gallbladder

Thyroid Cancer

• Some animal studies link long-term use of GLP-1 agonists to thyroid tumors

• Risk currently under review in human populations

We’re Investigating Claims Against These Drugmakers:

• Ozempic (Novo Nordisk)

• Wegovy (Novo Nordisk)

• Rybelsus (Novo Nordisk)

• Mounjaro (Eli Lilly)

• Trulicity (Eli Lilly)

We believe these companies may have failed to adequately warn patients and doctors about the full extent of potential risks.